TOKYO (ACN Newswire) -
SGX-listed Singapore eDevelopment Ltd (SeD) wishes to announce that US biomedical subsidiary Global BioLife Inc. will present research on 3F against tuberculosis at the 2020 ASM Biothreats Conference. ASM Biothreats will take place January 28 - 30, 2020 in Arlington, Virginia.
In Aug 2017, SeD announced that Global BioLife and Chemia Corp, a US company involved in providing high quality fragrances to manufacturers, would collaborate to develop a suite of fragrances called 3F (Functional Fragrance Formulation) to fight disease - in addition to smelling pleasant.
In Nov 2017, Global BioLife announced development of the first product labeled 3F Mosquito, deterrent technologies for fragrances, paints, and fabric.
Tuberculosis ("TB") is a disease caused by the Mycobacterium tuberculosis bacteria. TB, which primarily affects the lungs, is transmitted through the open air when an infected person sneezes, coughs, talks, or laughs. The symptoms of TB include a low-grade fever, night sweats, weakness or tiredness, and weight loss. TB kills someone approximately every 18 seconds, causing over 1.6 million deaths in 2017 alone. According to the World Health Organization, about one-quarter of the world's population has latent TB, which means people have been infected by TB bacteria but are not (yet) ill with the disease and cannot transmit the disease, making it the top infectious killer in the world.
"The impact of functional fragrances will transform the modern perfume industry", said Mr. Thomas A. Meyer, Chemia's Vice-President of Innovation and Sustainability.
Global BioLife Director of Scientific Initiatives Daryl Thompson has led this research. "3F is a new paradigm, designed to provide solutions for emerging epidemics and pandemics globally using cutting edge methods", says Thompson.
Global BioLife and Chemia Corporation had contracted American Type Culture Collection ("ATCC"), to conduct the testing in their High Containment Laboratory under Biosafety Level 3 conditions. ATCC was established in 1925 and is a leading developer and supplier of authenticated cells lines and microorganisms who designs custom services for testing the world's most dangerous viruses and bacteria.
Global BioLife also relies on the expertise of former U.S. Senior Assistant Surgeon General, Dr. Roscoe M. Moore Jr., who also served as an Epidemic Intelligence Service Officer with the U.S. Center for Disease Control and Prevention. Dr. Moore, Chief Epidemiologist of the Center for Devices and Radiological Health, U.S. Food and Drug Administration, said, "I am very excited about the results 3F has demonstrated. There is a strong need for new and effective measurement to address the spread of TB globally." Dr. Moore was recently appointed to the Board of Advisors of the Institute of Human Virology, School of Medicine, University of Maryland.
"It is an honor to be invited to present our groundbreaking research at the 2020 ASM Biothreat Conference", said SeD's Executive Chairman Mr. Chan Heng Fai.
ASM is one of the largest life science societies, with more than 30,000 members, including researchers, educators, and health professionals. The ASM Board of Directors supplies strategic direction to the society and focuses on biodefense and emerging diseases.
About Singapore eDevelopment Limited
Incorporated on 9 Sep 2009 and listed on the SGX in July 2010, Singapore eDevelopment Ltd (SGX:40V) is involved in (i) property in the US and W Australia; (ii) IT-related businesses; (iii) biomedical products; and (iv) investment activities. For more information, please visit: www.SeD.com.sg or email contact@sed.com.sg.
About Global BioLife Inc.
Global BioLife Inc, the US biomedical subsidiary of Singapore eDevelopment Ltd, is involved in drug discovery & development for neurological, oncological and immuno-related diseases. Global BioLife collaborates with Chemia Corp. to develop 3F (Functional Fragrance Formulation); the first product, 3F Mosquito, is made of specialised oils sourced from botanicals which mosquitoes avoid., which are N,N-Diethyl-meta-toluamide (a.k.a. DEET), to protect against mosquito transmitted diseases such as Zika and Dengue. For more information, please visit: www.globalbiolife.com.
In Aug 2017, SeD announced that Global BioLife and Chemia Corp, a US company involved in providing high quality fragrances to manufacturers, would collaborate to develop a suite of fragrances called 3F (Functional Fragrance Formulation) to fight disease - in addition to smelling pleasant.
In Nov 2017, Global BioLife announced development of the first product labeled 3F Mosquito, deterrent technologies for fragrances, paints, and fabric.
Tuberculosis ("TB") is a disease caused by the Mycobacterium tuberculosis bacteria. TB, which primarily affects the lungs, is transmitted through the open air when an infected person sneezes, coughs, talks, or laughs. The symptoms of TB include a low-grade fever, night sweats, weakness or tiredness, and weight loss. TB kills someone approximately every 18 seconds, causing over 1.6 million deaths in 2017 alone. According to the World Health Organization, about one-quarter of the world's population has latent TB, which means people have been infected by TB bacteria but are not (yet) ill with the disease and cannot transmit the disease, making it the top infectious killer in the world.
"The impact of functional fragrances will transform the modern perfume industry", said Mr. Thomas A. Meyer, Chemia's Vice-President of Innovation and Sustainability.
Global BioLife Director of Scientific Initiatives Daryl Thompson has led this research. "3F is a new paradigm, designed to provide solutions for emerging epidemics and pandemics globally using cutting edge methods", says Thompson.
Global BioLife and Chemia Corporation had contracted American Type Culture Collection ("ATCC"), to conduct the testing in their High Containment Laboratory under Biosafety Level 3 conditions. ATCC was established in 1925 and is a leading developer and supplier of authenticated cells lines and microorganisms who designs custom services for testing the world's most dangerous viruses and bacteria.
Global BioLife also relies on the expertise of former U.S. Senior Assistant Surgeon General, Dr. Roscoe M. Moore Jr., who also served as an Epidemic Intelligence Service Officer with the U.S. Center for Disease Control and Prevention. Dr. Moore, Chief Epidemiologist of the Center for Devices and Radiological Health, U.S. Food and Drug Administration, said, "I am very excited about the results 3F has demonstrated. There is a strong need for new and effective measurement to address the spread of TB globally." Dr. Moore was recently appointed to the Board of Advisors of the Institute of Human Virology, School of Medicine, University of Maryland.
"It is an honor to be invited to present our groundbreaking research at the 2020 ASM Biothreat Conference", said SeD's Executive Chairman Mr. Chan Heng Fai.
ASM is one of the largest life science societies, with more than 30,000 members, including researchers, educators, and health professionals. The ASM Board of Directors supplies strategic direction to the society and focuses on biodefense and emerging diseases.
About Singapore eDevelopment Limited
Incorporated on 9 Sep 2009 and listed on the SGX in July 2010, Singapore eDevelopment Ltd (SGX:40V) is involved in (i) property in the US and W Australia; (ii) IT-related businesses; (iii) biomedical products; and (iv) investment activities. For more information, please visit: www.SeD.com.sg or email contact@sed.com.sg.
About Global BioLife Inc.
Global BioLife Inc, the US biomedical subsidiary of Singapore eDevelopment Ltd, is involved in drug discovery & development for neurological, oncological and immuno-related diseases. Global BioLife collaborates with Chemia Corp. to develop 3F (Functional Fragrance Formulation); the first product, 3F Mosquito, is made of specialised oils sourced from botanicals which mosquitoes avoid., which are N,N-Diethyl-meta-toluamide (a.k.a. DEET), to protect against mosquito transmitted diseases such as Zika and Dengue. For more information, please visit: www.globalbiolife.com.
Industry: Daily Finance , Food & Beverage , BioTech , Healthcare & Pharm , Cosmetics, Spec.Chem